Search company, investor...

Founded Year



Acquired | Acquired

Total Raised




About mySugr

MySugr develops motivating and fun mobile apps to manage diabetes. The Companion is a charming, sometimes outspoken diabetes manager. The app has a similar purpose as a diabetes logbook. It provides immediate feedback and helps you stay motivated. users win points for every entry made which helps tame diabetes. mySugr Junior is a smart logbooking app that helps children, who still need their parents support, to master this great challenge day by day.

Headquarters Location

Trattnerhof 1

Vienna, 1010,


+43 720 884555



Research containing mySugr

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned mySugr in 1 CB Insights research brief, most recently on Oct 13, 2022.

Expert Collections containing mySugr

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

mySugr is included in 2 Expert Collections, including Digital Health.


Digital Health

10,585 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.


Precision Medicine Tech Market Map

160 items

This CB Insights Tech Market Map highlights 160 precision medicine companies that are addressing 9 distinct technology priorities that pharmaceutical companies and healthcare providers face.

mySugr Patents

mySugr has filed 5 patents.

The 3 most popular patent topics include:

  • diabetes
  • insulin therapies
  • blood tests
patents chart

Application Date

Grant Date


Related Topics




Image processing, Digital photography, Optical character recognition, Digital display connectors, Armidale-class patrol boats


Application Date


Grant Date



Related Topics

Image processing, Digital photography, Optical character recognition, Digital display connectors, Armidale-class patrol boats



Latest mySugr News

Frontiers Health Steering Committee spotlight – Fredrik Debong

Oct 7, 2022

October 7, 2022 As we enter October and the Frontiers Health 2022 conference in Milan, we’re shining a spotlight on some of the Steering Committee members who have helped make the event what it is. Here we talk to Fredrik Debong, who cofounded MySugr in 2012 and sold it to Roche Diabetes Care five years later in an eight- to nine-figure deal. A cooling off in digital health investment Digital health saw a major investment boom the last few years, egged on by COVID-19, as well as by the natural maturation of the market. Yet, as the virus has abated and the economy has slumped, investment has cooled off . This may not be cause for alarm, however; rather, it’s the end of Gartner’s “peak of inflated expectations” and the beginning of a realistic equilibrium. “Yeah, there’s been a lot of hype driven by public reimbursement for digital health, as well as simple things like symptom checkers, that aren’t very impactful unless they’re ecosystem plays,” Fredrik Debong, a health tech investor, cofounder of mySugr, and Frontiers Steering Committee member, tells pharmaphorum. “Also, one or two IPOs and mergers in the US haven’t really panned out to be epic for healthcare or financial outcomes. We are right now at the stage where we’re beginning to realize that, all right, we can build something and launch it on a broader scale, but it’s really hard to make it super big and impactful without cutting corners. And in health care you can’t cut corners, “ he says. Debong knows a thing or two about how hard it is to build a healthcare company with real value. And he’s not surprised that this year we’ve seen big bets like Amazon Care flop. “I believe that many big companies enter the field because it’s a “big market” and they have McKinsey and MBA students saying they need to do something in there, not because they want to strive to have a huge healthcare impact,” he says. “And those bets or leaps of faith based on spreadsheets and PowerPoints, not actual experience – they land you in hot waters.” The investments that will succeed Some high-profile misses aren’t a reason for pessimism about the ecosystem, Debong says – just realism. “I think it’s going to grow, but we’ll see more mature plays. There are enough of us who know what can be done now,” he said. “But the system and view on the field is changing. Many are coming to the realisation, like I did, that just building an island of a solution is nice, but it’s not going to be huge. You have to either change a horizontal layer of the ecosystem or craft really deep vertical, where you control and thus can work through the kinks of multiple layers yourself.” An ecosystem layer is a technology that has the capacity to enable a broad swathe of healthcare operations, often a data management or infrastructure play. A deep vertical, meanwhile, involves a technology “starting with the patient experience, going all the way down into the health economics and the machinations of society,” Debong says. “These are the two big things coming at us, I believe: deep vertical plays and the horizontal plays. They are the more interesting pieces, where more investment is needed,” he says. “I do help and connect with island plays, too, but I refrain from investing in such solutions nowadays.” When it comes to the horizontal plays, Debong sees two big categories. One is around payment and reimbursement. “Money is the glue of our healthcare systems. There is no getting around this essential horizontal layer,” Debong says. “Yet, the infrastructure for this is often burdensome for everyone involved in these three-way exchanges: the provider waits for the customer, who waits for their insurance, who waits for a document that may never come. As we notice now that a few of our colleagues offer reimbursed services, it all takes so long and requires a lot of work to make it run. This field needs a lot of loving and, if done well, enables huge leaps in healthcare access and transparency.” The other broad category is around data exchange. Because data is still not interoperable, there are a lot of great opportunities for companies to build services around easy data exchange. One example that he has invested in is German company Daslab, which unifies data coming from testing labs and then uses that data to improve testing efficiencies. “They’ve been able to integrate into the core systems of pretty much every diagnostic laboratory in Germany to such a level that they can tell the clinician which lab a vial needs to go to, for the result to be delivered on time,” Debong explains. “This makes it possible to expect to get the result in a day, and digitally, instead of waiting for a letter for a week. It’s huge: this is what a horizontal layer play looks like.” Making connections As it happens, Debong first met Daslab’s team at Frontiers Health. It’s also where he first encountered Praava, a Bangladeshi digital-enabled clinic he now advises. He sees major value in events that bring together entrepreneurs and investors who might be able to help support each other, either financially or just by sharing ideas and solutions to problems. “That honesty and support from within the network is simply tremendous,” Debong says. “That’s why you go there. That openness and helpfulness across all these domains of healthcare, across borders and established peer groups. Some of my best friends are new entrepreneurs and VC’s; others are veterans. Frontiers is this dissolvent and glue in the European digital health ecosystem.” And check out DTx and National Health Systems from last year’s event below.

mySugr Frequently Asked Questions (FAQ)

  • When was mySugr founded?

    mySugr was founded in 2012.

  • Where is mySugr's headquarters?

    mySugr's headquarters is located at Trattnerhof 1, Vienna.

  • What is mySugr's latest funding round?

    mySugr's latest funding round is Acquired.

  • How much did mySugr raise?

    mySugr raised a total of $6.17M.

  • Who are the investors of mySugr?

    Investors of mySugr include Roche, Roche Venture Fund, iSeed Ventures, XLHEALTH and PUSH Ventures.

  • Who are mySugr's competitors?

    Competitors of mySugr include BeatO, Zhiyun Health, DIABNEXT, Omada Health, Hedia and 7 more.


Compare mySugr to Competitors

One Drop Logo
One Drop

One Drop operates as a diabetes management platform. It allows users to track their glucose levels using a variety of devices, including blood glucose meters, continuous glucose monitors (CGMs), and insulin pumps. It also offers a mobile application that provides personalized coaching to help users achieve their health goals. The company was founded in 2014 and is based in New York, New York.

Emperra Logo

Emperra is a research and innovation-oriented medical technology company with a focus on Health-IT and tele-diabetology. The company offers a comprehensive, state-of-the-art, and AI-enabled diabetes management solution that aids individuals with diabetes in managing their metabolic conditions and assists healthcare professionals in their daily practice. The primary sector that Emperra serves is the healthcare industry, specifically in the area of diabetes management. It was founded in 2008 and is based in Potsdam, Germany.

Life In Control Logo
Life In Control

Curo Healthcare Technologies runs Life In Control, a digital diabetes management program. The Life in Control app, which is available both in Android and iOS platforms, is designed to connect doctors and patients to help patients better manage their glycemic status in collaboration with their doctors. It also analyzes patients' historical data to predict secondary complications aimed at preventing diabetes and promoting wellness.

BeatO Logo

BeatO develops diabetes care and management application to manage and prevent health problems. It offers health monitoring, health insights, daily coaching from experts, health plans, nutrition support, lab tests, and pharmacy. The company offers smartphone glucometers and connected monitoring devices helping users to monitor and get guidance for blood sugar, blood pressure, and other health vitals. The company was founded in 2015 and is based in New Delhi, India.

WellDoc Logo

WellDoc is a company that focuses on the healthcare technology sector, specifically in the domain of chronic care management. The company offers an AI-driven digital coaching platform that aids in the self-management of various chronic conditions such as diabetes, hypertension, heart failure, and obesity. The platform also provides data-driven insights to support care team interventions and decision making, and promotes general wellness and education. WellDoc primarily serves health plans, health systems, employers, and partners in the healthcare industry. It was founded in 2005 and is based in Baltimore, Maryland.

Glooko Logo

Glooko is a company that focuses on improving health outcomes for individuals with diabetes and related chronic conditions, operating within the healthcare and digital health sectors. The company offers a connected care platform that provides personalized care, drives patient engagement and adherence through digital therapeutics, and accelerates the speed of clinical trials. Glooko primarily serves the healthcare industry, with a particular focus on providers and patients dealing with chronic conditions. Glooko was formerly known as OTA Health Inc.. It was founded in 2010 and is based in Palo Alto, California.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.